Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market GLP-1 drugs are reshaping healthcare and consumer markets
In contrast, while the dose-response relationship between -cell responsiveness to glucose (expressed as the slope of the linear relation between insulin secretion rate and the glucose concentration) and GLP-1 levels in circulation is partially impaired a phenomenon referred as GLP-1 resistance (62) a therapeutic infusion of GLP-1 at a pharmacological dose can restore -cell insulin secretion responsiveness to glucose levels comparable to those observed in nondiabetic individuals (62)
Their expanding role beyond weight management and glycemic control presents new considerations for bone remodeling, perioperative risk reduction, and postoperative recovery in orthopedic surgery
For now, the study provides reassurance, not a green light to continue GLP-1 medications during pregnancy without medical guidance.
While the two litigation tracks remain separate, the JPML noted significant overlap between the cases, making it efficient for Judge Marston to handle both MDLs since they involve the same attorneys and defendants
These companies currently offer five GLP-1 drugs approved for type 2 diabetes, with four also approved for various cardiovascular conditions
